Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urea treatment of hyponatremia during subarachnoid hemorrhage
2020-001084-83Phase 3Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of urea in hyponatraemia, sponsored by CHU Grenoble Alpes. Primary endpoint: Change in serum sodium concentration. Started Apr 2020; status: active.
02
Drugs
urea
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on 2020-001084-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001084-83.